Display options
Cite
Pantziarka P, Hutchinson L, André N, et al. Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai. Ecancermedicalscience. 2016;10:689doi: 10.3332/ecancer.2016.689.
Pantziarka, P., Hutchinson, L., André, N., Benzekry, S., Bertolini, F., Bhattacharjee, A., Chiplunkar, S., Duda, D. G., Gota, V., Gupta, S., Joshi, A., Kannan, S., Kerbel, R., Kieran, M., Palazzo, A., Parikh, A., Pasquier, E., Patil, V., Prabhash, K., Shaked, Y., Sholler, G. S., Sterba, J., Waxman, D. J., & Banavali, S. (2016). Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai. Ecancermedicalscience, 10689. https://doi.org/10.3332/ecancer.2016.689
Pantziarka, Pan, et al. "Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai." Ecancermedicalscience vol. 10 (2016): 689. doi: https://doi.org/10.3332/ecancer.2016.689
Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S. Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai. Ecancermedicalscience. 2016 Nov 02;10:689. doi: 10.3332/ecancer.2016.689. eCollection 2016. PMID: 27994645; PMCID: PMC5130328.
Copy Download .nbib Format: NLM
Share it on

Ecancermedicalscience. 2016 Nov 02;10:689. doi: 10.3332/ecancer.2016.689. eCollection 2016.

Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.

Ecancermedicalscience

Pan Pantziarka, Lisa Hutchinson, Nicolas André, Sébastien Benzekry, Francesco Bertolini, Atanu Bhattacharjee, Shubhada Chiplunkar, Dan G Duda, Vikram Gota, Sudeep Gupta, Amit Joshi, Sadhana Kannan, Robert Kerbel, Mark Kieran, Antonella Palazzo, Aparna Parikh, Eddy Pasquier, Vijay Patil, Kumar Prabhash, Yuval Shaked, Giselle Saulnier Sholler, Jaroslav Sterba, David J Waxman, Shripad Banavali

Affiliations

  1. Anticancer Fund, Brussels, 1853 Strombeek-Bever, Belgium; The George Pantziarka TP53 Trust, London, UK.
  2. Nature Reviews Clinical Oncology, London N1 9XW, UK.
  3. Service d'hématologie et Oncologie Pédiatrique, Centre Hospitalo-Universitaire Timone Enfants, AP-HM, Aix-Marseille Université, INSERM, CRO2 UMR_S 911, Marseille, France; Metronomics Global Health Initiative, Marseille, France.
  4. Inria team MONC and Institut de Mathématiques de Bordeaux, Talence, France.
  5. European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy.
  6. Malabar Cancer Centre, Thalassery, India.
  7. ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai 410210, India.
  8. Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  9. Tata Memorial Hospital, Mumbai, India.
  10. Biological Sciences Platform, Sunnybrook Research Institute, University of Toronto, Toronto, ON, Canada.
  11. Dana-Farber Cancer Institute, Boston, MA, USA.
  12. Division of Medical Senology, European Institute of Oncology, Via Ripamonti 435, 20141, Milan, Italy.
  13. PRA Health Sciences, Mumbai, India.
  14. INSERM UMR 911, Centre de Recherche en Oncologie Biologique et Oncopharmacologie, Aix-Marseille University, Marseille, France; Metronomics Global Health Initiative, Marseille, France.
  15. Department of Cell Biology and Cancer Science, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  16. Helen DeVos Children's Hospital, Grand Rapids, Michigan, USA.
  17. Department of Pediatric Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Cernopolni 9, 613 00 Brno, Czech Republic; International Clinical Research Center, St. Anne's University Hospital and RECAMO, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  18. Department of Biology, Boston University, Boston, MA 02215, USA.
  19. Tata Memorial Hospital, Mumbai, India; Metronomics Global Health Initiative, Marseille, France.

PMID: 27994645 PMCID: PMC5130328 DOI: 10.3332/ecancer.2016.689

Abstract

The 5

Keywords: LMIC; Metronomic chemotherapy; anti-angiogenics; cancer; drug repurposing

References

  1. Lancet. 2015 May 9;385(9980):1843-52 - PubMed
  2. Cancer Res. 2011 Nov 15;71(22):6986-96 - PubMed
  3. Indian J Cancer. 2013 Apr-Jun;50(2):135-41 - PubMed
  4. Ann Oncol. 2012 Aug;23 Suppl 6:vi35-9 - PubMed
  5. Blood. 2006 Jul 15;108(2):452-9 - PubMed
  6. Hepatology. 2014 Apr;59(4):1435-47 - PubMed
  7. Oncoscience. 2014 Mar 12;1(2):167-179 - PubMed
  8. Nat Rev Cancer. 2011 Feb;11(2):135-41 - PubMed
  9. BMC Cancer. 2015 May 08;15:375 - PubMed
  10. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007814 - PubMed
  11. Clin Cancer Res. 2009 Dec 15;15(24):7652-7657 - PubMed
  12. Carcinogenesis. 2014 May;35(5):1055-66 - PubMed
  13. Cancer Res. 2012 Mar 1;72(5):1103-15 - PubMed
  14. Nat Rev Clin Oncol. 2009 Jun;6(6):327-38 - PubMed
  15. J Clin Oncol. 2005 Feb 10;23 (5):939-52 - PubMed
  16. South Asian J Cancer. 2016 Apr-Jun;5(2):37-47 - PubMed
  17. J Cancer Res Ther. 2012 Jan;8 Suppl 1:S106-10 - PubMed
  18. Angiogenesis. 2012 Jun;15(2):275-86 - PubMed
  19. ISRN Cell Biol. 2012;2012:null - PubMed
  20. Immunity. 2016 Feb 16;44(2):343-54 - PubMed
  21. Nature. 2014 Jun 5;510(7503):92-101 - PubMed
  22. Nature. 2016 Jan 21;529(7586):351-7 - PubMed
  23. Oncologist. 2010;15(6):577-83 - PubMed
  24. BMC Cancer. 2016 Apr 20;16:278 - PubMed
  25. Nat Rev Clin Oncol. 2010 Aug;7(8):455-65 - PubMed
  26. Clin Oncol (R Coll Radiol). 2013 Jun;25(6):388 - PubMed
  27. BMC Cancer. 2016 Aug 11;16:623 - PubMed
  28. Int J Cancer. 2016 Aug 15;139(4):869-81 - PubMed
  29. J Clin Oncol. 2009 Jun 20;27(18):3027-35 - PubMed
  30. N Engl J Med. 2008 Jun 12;358(24):2649-51 - PubMed
  31. Mol Cancer Ther. 2007 Aug;6(8):2280-9 - PubMed
  32. Blood. 2005 Nov 1;106(9):3058-61 - PubMed
  33. South Asian J Cancer. 2016 Apr-Jun;5(2):48-51 - PubMed
  34. J Clin Oncol. 2011 Jul 1;29(19):2645-52 - PubMed
  35. Clin Breast Cancer. 2015 Aug;15(4):259-65 - PubMed
  36. Mol Cancer Ther. 2014 Jan;13(1):202-13 - PubMed
  37. Nat Rev Clin Oncol. 2015 Apr;12(4):213-26 - PubMed
  38. Br J Cancer. 2013 Jun 25;108(12):2485-94 - PubMed
  39. Nature. 1956 Dec 22;178(4547):1391-2 - PubMed
  40. Lancet Oncol. 2012 May;13(5):549-58 - PubMed
  41. Cancer Treat Rev. 2014 Sep;40(8):942-50 - PubMed
  42. J Clin Invest. 2000 Apr;105(8):R15-24 - PubMed
  43. Cancer Med. 2013 Aug;2(4):427-36 - PubMed
  44. Mol Cancer Ther. 2008 Jan;7(1):79-89 - PubMed
  45. Neoplasia. 2014 Jan;16(1):84-96 - PubMed
  46. N Engl J Med. 2012 Mar 8;366(10):883-92 - PubMed
  47. Oncology. 2012;82(5):249-60 - PubMed
  48. Acta Neuropathol Commun. 2013 May 20;1:17 - PubMed
  49. Pediatr Blood Cancer. 2014 Apr;61(4):636-42 - PubMed
  50. Ecancermedicalscience. 2014 Nov 26;8:485 - PubMed
  51. Anesth Analg. 2010 Jun 1;110(6):1630-5 - PubMed
  52. Oral Oncol. 2015 Mar;51(3):279-86 - PubMed
  53. Nat Rev Clin Oncol. 2015 Dec;12(12):732-42 - PubMed
  54. J Natl Cancer Inst. 2016 Apr 08;108(8):null - PubMed
  55. J Clin Oncol. 2011 Aug 1;29(22):3085-96 - PubMed
  56. Lancet Oncol. 2013 May;14(6):e239-48 - PubMed
  57. Eur J Cancer. 2013 Nov;49(16):3387-95 - PubMed
  58. Cancer Cell. 2005 Jan;7(1):101-11 - PubMed
  59. Proc Natl Acad Sci U S A. 2015 Feb 3;112(5):1547-52 - PubMed
  60. Immunity. 2016 Mar 15;44(3):698-711 - PubMed
  61. Ecancermedicalscience. 2015 Jan 08;9:499 - PubMed
  62. Cancer Chemother Rep. 1964 Feb;35:1-111 - PubMed
  63. Clin Cancer Res. 2007 Feb 1;13(3):972-6 - PubMed
  64. Nat Rev Neurosci. 2007 Aug;8(8):610-22 - PubMed
  65. Cancer Res. 2013 May 1;73(9):2743-8 - PubMed
  66. Semin Cancer Biol. 2015 Dec;35:53-61 - PubMed
  67. South Asian J Cancer. 2016 Apr-Jun;5(2):52-5 - PubMed
  68. J Theor Biol. 2003 Feb 21;220(4):545-54 - PubMed
  69. Mol Cancer. 2014 Jun 26;13:158 - PubMed
  70. Cancer Cell. 2014 Nov 10;26(5):605-22 - PubMed
  71. Ecancermedicalscience. 2014 Jul 10;8:442 - PubMed
  72. EBioMedicine. 2016 Apr;6:87-95 - PubMed
  73. Oncotarget. 2015 Sep 29;6(29):27537-54 - PubMed
  74. Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14325-30 - PubMed
  75. Oncotarget. 2011 Dec;2(12):960-5 - PubMed
  76. J Clin Invest. 2012 Jan;122(1):178-91 - PubMed
  77. Nat Rev Clin Oncol. 2016 Nov;13(11):659-673 - PubMed
  78. Oncotarget. 2011 Oct;2(10):797-809 - PubMed
  79. J Natl Cancer Inst. 1996 Aug 7;88(15):1039-45 - PubMed
  80. J Clin Oncol. 2003 Apr 15;21(8):1431-9 - PubMed
  81. Cancer Cell. 2015 Dec 14;28(6):690-714 - PubMed
  82. Clin Cancer Res. 2011 Apr 15;17(8):2074-80 - PubMed
  83. Cancer Res. 2009 Jun 1;69(11):4894-903 - PubMed
  84. Proc Natl Acad Sci U S A. 2016 Apr 19;113(16):4470-5 - PubMed
  85. Transl Pediatr. 2015 Jul;4(3):226-38 - PubMed
  86. Cancer Res. 2011 Jan 1;71(1):19-28 - PubMed
  87. Cancer Res. 2003 Aug 1;63(15):4342-6 - PubMed
  88. J Clin Oncol. 2011 Jul 1;29(19):2635-44 - PubMed
  89. Oncologist. 2013;18(12):1248-55 - PubMed
  90. Int J Cancer. 2015 Mar 15;136(6):E534-44 - PubMed
  91. Indian J Cancer. 2013 Oct-Dec;50(4):330-2 - PubMed
  92. Nat Rev Cancer. 2012 Mar 15;12 (4):298-306 - PubMed
  93. Hepatology. 2015 May;61(5):1591-602 - PubMed
  94. Cancer Res. 2005 Aug 15;65(16):7045-51 - PubMed
  95. Oncotarget. 2016 Jul 19;7(29):46813-46831 - PubMed
  96. Ecancermedicalscience. 2014 Sep 09;8:463 - PubMed
  97. Nat Rev Immunol. 2008 May;8(5):349-61 - PubMed
  98. Am J Clin Nutr. 2010 Nov;92(5):1151-6 - PubMed
  99. Cancer Res. 2000 Apr 1;60(7):1878-86 - PubMed
  100. Ann Oncol. 2010 Oct;21 Suppl 7:vii252-61 - PubMed
  101. Oncoimmunology. 2015 Feb 18;4(4):e1005521 - PubMed
  102. Nat Rev Cancer. 2004 Jun;4(6):423-36 - PubMed
  103. Cancer Treat Rep. 1977 Oct;61(7):1307-17 - PubMed
  104. Neoplasia. 2014 Jun;16(6):501-10 - PubMed
  105. Exp Cell Res. 2013 Jul 1;319(11):1687-95 - PubMed
  106. Science. 1976 Oct 1;194(4260):23-8 - PubMed
  107. Ann Surg Oncol. 2008 Jul;15(7):2042-52 - PubMed
  108. Nat Rev Clin Oncol. 2016 Oct;13(10):611-26 - PubMed
  109. PLoS One. 2015 May 27;10(5):e0127246 - PubMed
  110. Am J Pathol. 2010 Oct;177(4):1576-91 - PubMed
  111. Cancer Res. 2009 Jul 1;69(13):5296-300 - PubMed
  112. Cancer Lett. 2014 Nov 28;354(2):220-6 - PubMed

Publication Types

Grant support